Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Pentaglobin, also known as IgM-enriched immunoglobulin, falls under a group of polyclonal immunoglobulin preparations. It is comprised of immunoglobulin G (IgG) (https://www.drugbank.ca/drugs/DB00028) and immunoglobulin A (IgA) while also being enriched...
- Mechanism
- Curator reviewed · 2 references
Pentaglobin has potential antibacterial and immunomodulatory properties where, compared to immunoglobulin treatments without IgM, pentaglobin may have an increased ability to eliminate infectious pathogens. The IgM in the preparation plays a role in complement activation and neutralization of bacterial endo- and exotoxins. Pentaglobin is used as an adjuvant in treatment of severe bacterial infections while it is also investigated against peritonitis, sepsis, and COVID-19.
- Also known as
- IgM-enriched immunoglobulins · IVIgGM
- Code names
- Pentaglobin
Resolves to
What you can answer from here — as of July 08, 2026
Which drugs share a target with Pentaglobin, and which of those have an active Phase 3 trial?